Results 181 to 190 of about 51,875 (217)

Rifampin in the Treatment of Leprosy

Clinical Infectious Diseases, 1983
The minimal inhibitory concentration of rifampin for Mycobacterium leprae is less than 1 microgram/ml. Therapy with rifampin has proved efficacious both in mice experimentally infected with M. leprae and in humans with leprosy. Rifampin kills M. leprae more rapidly than do other antileprosy drugs currently available. Consequently, M.
openaire   +2 more sources

Rifampin in dermatology

Clinics in Dermatology, 2003
Nikolai, Tsankov, Irena, Angelova
openaire   +3 more sources

If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study.

Clinical Infectious Diseases, 2021
Wierd P Zijlstra, Marjan Wouthuyzen-Bakker, Claudia A M Löwik   +2 more
exaly  

Rifampin

Pediatrics In Review, 2004
openaire   +3 more sources

RifAMPin

2022
Michelle C. Simpson, Eric G. Schaefer
openaire   +1 more source

Rifampin

2021
openaire   +2 more sources

Rifampin

Tuberculosis, 2008
openaire   +2 more sources

The Place of Rifampin

Chest, 1972
openaire   +2 more sources

MIXING RIFAMPIN

The Pediatric Infectious Disease Journal, 1983
openaire   +2 more sources

Rifampin

2011
Gaurav Rajpal, Manuel C. Vallejo
openaire   +2 more sources